Allogene Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANNX
|
Annexon, Inc. | $5.13 | $523.15 M | -3.93 | 71 | $0 |
 BEAM
|
Beam Therapeutics Inc. | $25.04 | $1.91 B | -14.51 | 472 | $377.71 M |
 BPMC
|
Blueprint Medicines Corporation | $94.15 | $6.47 B | -21.48 | 638 | $249.38 M |
 CRBU
|
Caribou Biosciences, Inc. | $2.01 | $176.12 M | -1.41 | 158 | $34.48 M |
 EDIT
|
Editas Medicine, Inc. | $2.44 | $435.86 M | -2.56 | 265 | $78.12 M |
 GTHX
|
G1 Therapeutics, Inc. | $7.16 | $157.37 M | -5.02 | 100 | $82.51 M |
 HRTX
|
Heron Therapeutics, Inc. | $1.08 | $542.35 M | -6.55 | 126 | $127.04 M |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 IPSC
|
Century Therapeutics, Inc. | $1.20 | $244.54 M | -1.32 | 152 | $2.24 M |
 ITOS
|
iTeos Therapeutics, Inc. | $8.33 | $603.25 M | -4.42 | 157 | $12.60 M |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 NTLA
|
Intellia Therapeutics, Inc. | $14.29 | $2.19 B | -4.23 | 526 | $36.28 M |
 PRME
|
Prime Medicine, Inc. | $3.20 | $788.60 M | -3.01 | 234 | $0 |
 RLAY
|
Relay Therapeutics, Inc. | $4.74 | $1.05 B | -3 | 294 | $25.55 M |
 SANA
|
Sana Biotechnology, Inc. | $2.60 | $1.55 B | -4.59 | 328 | $0 |
 SGMO
|
Sangamo Therapeutics, Inc. | $1.87 | $119.17 M | -0.31 | 405 | $176.23 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VECT
|
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
 VERV
|
Verve Therapeutics, Inc. | $4.84 | $409.24 M | -1.82 | 255 | $11.76 M |